Palvella Therapeutics has successfully obtained a European patent for its innovative formulation, QTORIN™, which includes anhydrous compositions of rapamycin. This patent marks a significant milestone in...
Chinese car manufacturers are increasingly gaining traction in the European market, successfully taking market share from other Asian brands rather than local competitors. This shift reflects...
